CLA-20795-69945
5 vaccinations
10 coded responses
56 check-ins
10 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 66+
- ZIP prefix
- 994 / WA
- Registered
- 2021-02-04
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-29
Dose 1 — Pfizer-BioNTech
-
2021-02-04
Registered in v-safe
- 2021-02-05
- 2021-02-12
-
2021-02-19
Dose 2 — Pfizer-BioNTech
- 2021-02-19
-
2021-02-20
Survey response — days 1–6 daily, dose 2MedDRA: Blood pressure decreased, Dizziness — Feeling: Good · Site: PainFree text: Dizziness, lower than normal blood pressure readingsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-21
Survey response — days 1–6 daily, dose 2MedDRA: Hypotension — Feeling: Good · Site: PainFree text: Episodes of low blood pressureMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-22
- 2021-02-23
- 2021-02-24
- 2021-02-25
- 2021-02-26
- 2021-03-05
- 2021-03-12
- 2021-03-19
- 2021-03-26
- 2021-04-02
- 2021-05-22
- 2021-08-20
-
2021-09-29
Dose 3 — Pfizer-BioNTech
- 2021-09-29
-
2021-09-30
Survey response — days 1–6 daily, dose 3MedDRA: Blood glucose abnormal — Feeling: Good · Site: PainFree text: Having a minor issue with managing blood sugar: had to raise basal rate on insulin pump by 10 percentMedDRA releases: 2024-11 · check-in free text available
- 2021-10-01
-
2021-10-02
Survey response — days 1–6 daily, dose 3MedDRA: No adverse event — Feeling: Good · Site: ItchingFree text: NoMedDRA releases: 2024-11 · check-in free text available
-
2021-10-03
Survey response — days 1–6 daily, dose 3MedDRA: No adverse event — Feeling: GoodFree text: NoMedDRA releases: 2024-11 · check-in free text available
-
2021-10-04
Survey response — days 1–6 daily, dose 3MedDRA: No adverse event — Feeling: GoodFree text: NoMedDRA releases: 2024-11 · check-in free text available
-
2021-10-05
Survey response — days 1–6 daily, dose 3MedDRA: No adverse event — Feeling: GoodFree text: NoMedDRA releases: 2024-11 · check-in free text available
-
2021-10-06
Survey response — day 7, dose 3MedDRA: No adverse event — Feeling: GoodFree text: NoMedDRA releases: 2024-11 · check-in free text available
- 2021-10-13
- 2021-10-20
- 2021-10-27
- 2021-11-03
- 2021-11-10
- 2021-12-29
- 2022-03-30
-
2022-04-20
Dose 4 — Pfizer-BioNTech
- 2022-04-20
- 2022-04-21
- 2022-04-22
- 2022-04-23
- 2022-04-24
- 2022-04-25
- 2022-04-26
- 2022-04-27
- 2022-05-04
- 2022-05-11
- 2022-05-18
- 2022-05-25
- 2022-06-01
- 2022-07-20
-
2022-09-16
Dose 5 — Pfizer-BioNTech
-
2022-09-20
Survey response — days 1–6 daily, dose 5MedDRA: Injection site pain — Feeling: Good · Site: PainFree text: This is the first day I have had any pain at the injection site (4 days after I got the shot)MedDRA releases: 2024-11 · check-in free text available
- 2022-09-21
- 2022-09-22
- 2022-09-23
- 2022-09-30
- 2022-10-07
- 2022-10-21
- 2022-10-28
-
2022-12-16
Survey response — 3 months, dose 5MedDRA: COVID-19, Pre-existing disease — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visitFree text: Had COVID. Diagnosed on 11/23/22. Took Paxlovid which was very helpful and prevented serious respiratory symptoms associated with reactive airway disorder and asthma I usually experience with any respiratory virus. Symptoms lasted approx 2.5 weeksMedDRA releases: 2024-11 · check-in free text available
-
2022-12-16
Report sent to call center — 3 months, dose 5Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalEmergency room or emergency department visit · 1 call case(s)
-
2022-12-20
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
- 2023-03-17
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-29 | Pfizer-BioNTech | |
| 2 | 2021-02-19 | Pfizer-BioNTech | |
| 3 | 2021-09-29 | Pfizer-BioNTech | No |
| 4 | 2022-04-20 | Pfizer-BioNTech | No |
| 5 | 2022-09-16 | Pfizer-BioNTech | No |
Call center
1 call center case
1 successful
Free text
Release 4 — days 1–6 daily, dose 2
Systemic reaction (other): Dizziness, lower than normal blood pressure readings
Systemic reaction (other): Episodes of low blood pressure
Release 9 — days 1–6 daily, dose 3
Systemic reaction (other): Having a minor issue with managing blood sugar: had to raise basal rate on insulin pump by 10 percent
Systemic reaction (other): No
Systemic reaction (other): No
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): No
Systemic reaction (other): No
Release 10 — day 7, dose 3
Systemic reaction (other): No
Release 12 — days 1–6 daily, dose 5
Systemic reaction (other): This is the first day I have had any pain at the injection site (4 days after I got the shot)
Release 12 — 3 months, dose 5
Symptoms: Had COVID. Diagnosed on 11/23/22. Took Paxlovid which was very helpful and prevented serious respiratory symptoms associated with reactive airway disorder and asthma I usually experience with any respiratory virus. Symptoms lasted approx 2.5 weeks
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SRO | Blood glucose abnormal | · | · | ✓ |
| SRO | Blood pressure decreased | ✓ | ✓ | ✓ |
| SRO | Dizziness | ✓ | ✓ | ✓ |
| SRO | Hypotension | ✓ | ✓ | ✓ |
| SRO | Injection site pain | · | · | ✓ |
| SRO | No adverse event | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release